- date: 17. November 2024
  headline: "Congratulation! <b>Baifeng's the co-first authored paper entitled GPRC5A promotes lung colonization of esophageal squamous cell carcinoma</b> <a href='https://doi.org/10.1038/s41467-024-54251-9'>is published in Nature Communications</a>!"

- date: 21. October 2024
  headline: "Congratulation! <b>Baifeng's the co-first authored paper entitled QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion</b> <a href='https://doi.org/10.1073/pnas.2407506121'>is published in PNAS</a>!"

- date: 02. August 2024
  headline: "<b>Congratulation to Dr. Baifeng Zhang on his successful PhD denfense</b>!"

- date: 10. October 2023
  headline: "Congratulation! <b>Baifeng's the co-first authored paper entitled Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma</b> <a href='https://doi.org/10.1073/pnas.2307914120'>is published in PNAS</a>!"

- date : 14-16. June 2023
  headline: "Baifeng is invited to give a short talk on <b>Metastatic microenvironment of ESCC</b> in <a href='http://ias.ust.hk/events/202306bam/program.php'>IAS International Workshop on Biological data science, AI & Medicine (BAM workshop) hosted by HKUST IAS (June 14-16)</a>"

- date : 14-19. April 2023
  headline: "Baifeng is selected for poster presentation on <b>Pan-cancer single-cell analysis reveals the interactions of SPP1+MMP12+ macrophages with metastasis-initiating cells that drives metastasis</b> in <a href='https://aacrjournals.org/cancerres/article/83/7_Supplement/4699/722703/Abstract-4699-Pan-cancer-single-cell-analysis'>AACR Annual Meeting 2023 in Orlando, Florida (April 14-19)</a>"

- date: 29. January 2023
  headline: "Congratulation! <b>Baifeng's the co-first authored paper entitled Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma</b> <a href='https://doi.org/10.1002/advs.202204565'>is published in Advanced Science</a>!"

- date: 24. January 2023
  headline: "Congratulation! <b>Baifeng's the co-authored paper entitled Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in hepatocellular carcinoma</b> <a href='https://doi.org/10.1097/hep.0000000000000299'>is published in Hepatology</a>!"

- date: 10. December 2022
  headline: "Congratulation! <b>Baifeng's the corresponding-authored paper entitled Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer</b> <a href='https://doi.org/10.1002/1878-0261.13360'>is published in Molecular Oncology</a>!"

- date: 26. November 2022
  headline: "Congratulation! <b>Baifeng's the corresponding-authored paper entitled A prognostic risk model for glioma patients by systematic evaluation of genomic variations</b> <a href='https://doi.org/10.1016/j.isci.2022.105681'>is published in iScience</a>!"

- date: 29. September 2022
  headline: "Congratulation! <b>Baifeng's the co-authored paper entitled Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer</b> <a href='https://doi.org/10.1186/s13046-022-02449-4'>is published in Journal of Experimental & Clinical Cancer Research</a>!"

- date: 25. May 2022
  headline: "Congratulation! <b>Baifeng's the co-authored paper entitled Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma</b> <a href='https://doi.org/10.1186/s13046-022-02401-6'>is published in Journal of Experimental & Clinical Cancer Research</a>!"

- date: 23. August 2021
  headline: "Congratulation! <b>Baifeng's the first-authored paper on mutational signature anlaysis of HCC patients</b> <a href='https://hrjournal.net/article/view/4278'>is published in Hepatoma Research</a>!"

- date: 09. March 2021
  headline: "Congratulation! <b>Baifeng's co-authored paper on scRNAseq of Chinese NPC patients</b> <a href='https://www.nature.com/articles/s41467-021-21795-z'>is published in Nature Communications</a>!"

- date: 01. January 2021
  headline: "Congratulation! <b>Baifeng is admitted by Department of Clinical Oncology in Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) and start his Ph.D. study under the supervision of Prof. Xinyuan Guan and Prof. Dora Lai-wan KWONG</b>"

- date: 01. August 2020
  headline: "Congratulation! <b>Baifeng's the first-authored paper on SplitFusion software</b> <a href='https://www.researchsquare.com/article/rs-39138/v1'>is posted in Research Square and under review in Nature Biomedical Engineering</a>!"  

- date: 01. May 2020
  headline: "Congratulation! <b>Baifeng's co-first authored paper on chinese HGSOC omics study</b> <a href='https://www.sciencedirect.com/science/article/pii/S0090825820309884'>is published in Gynecologic Oncology</a>!"  

- date: 01. June 2019
  headline: "Congratulation! — Baifeng's wechat blog (<b>ID: CancerEvolution</b>) on cancer evolution and immune evasion  is officially starting!"

- date: 18. March 2019
  headline: "Congratulation! <b>Baifeng's the corresponding-authored paper on clonal evolution</b> <a href='https://www.nature.com/articles/s41467-019-09241-7'>is published in Nature Communications</a>! <img src='/images/newspic/2news.png' class='img-responsive' style='max-width: 192px' />"  

- date : 07-09. November 2018
  headline: "Baifeng is invited to give a short talk on <b>SplitFusion software</b> in <a href='http://ias.ust.hk/events/201811nttag/'>New Technologies and Translational Applications in Genomics international conference hosted by HKUST IAS (November 7-9)</a>"

- date: 01. Octorber 2018
  headline: "Welcome — <b> Baifeng's homepage is officially starting</b>!"
